Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2003

Open Access 01-12-2003 | Review

Innate immune defences in the human endometrium

Authors: Anne E King, Hilary OD Critchley, Rodney W Kelly

Published in: Reproductive Biology and Endocrinology | Issue 1/2003

Login to get access

Abstract

The human endometrium is an important site of innate immune defence, giving protection against uterine infection. Such protection is critical to successful implantation and pregnancy. Infection is a major cause of preterm birth and can also cause infertility and ectopic pregnancy. Natural anti-microbial peptides are key mediators of the innate immune system. These peptides, between them, have anti-bacterial, anti-fungal and anti-viral activity and are expressed at epithelial surfaces throughout the female genital tract. Two families of natural anti-microbials, the defensins and the whey acidic protein (WAP) motif proteins, appear to be prominent in endometrium. The human endometrial epithelium expresses beta-defensins 1–4 and the WAP motif protein, secretory leukocyte protease inhibitor. Each beta-defensin has a different expression profile in relation to the stage of the menstrual cycle, providing potential protection throughout the cycle. Secretory leukocyte protease inhibitor is expressed during the secretory phase of the cycle and has a range of possible roles including anti-protease and anti-microbial activity as well as having effects on epithelial cell growth. The leukocyte populations in the endometrium are also a source of anti-microbial production. Neutrophils are a particularly rich source of alpha-defensins, lactoferrin, lysozyme and the WAP motif protein, elafin. The presence of neutrophils during menstruation will enhance anti-microbial protection at a time when the epithelial barrier is disrupted. Several other anti-microbials including the natural killer cell product, granulysin, are likely to have a role in endometrium. The sequential production of natural anti-microbial peptides by the endometrium throughout the menstrual cycle and at other sites in the female genital tract will offer protection from many pathogens, including those that are sexually transmitted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Noyes RW, Hertig AT, Rock J: Dating the Endometrial Biopsy. Fertil. Steril. 1950, 1: 3-25. Noyes RW, Hertig AT, Rock J: Dating the Endometrial Biopsy. Fertil. Steril. 1950, 1: 3-25.
2.
go back to reference Cole AM, Liao HI, Stuchlik O, Tilan J, Pohl J, Ganz T: Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol. 2002, 169: 6985-6991.CrossRefPubMed Cole AM, Liao HI, Stuchlik O, Tilan J, Pohl J, Ganz T: Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol. 2002, 169: 6985-6991.CrossRefPubMed
3.
go back to reference Hancock RE, Diamond G: The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 2000, 8: 402-410. 10.1016/S0966-842X(00)01823-0.CrossRefPubMed Hancock RE, Diamond G: The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 2000, 8: 402-410. 10.1016/S0966-842X(00)01823-0.CrossRefPubMed
4.
go back to reference Huttner KM, Bevins CL: Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 1999, 45: 785-794.CrossRefPubMed Huttner KM, Bevins CL: Antimicrobial peptides as mediators of epithelial host defense. Pediatr. Res. 1999, 45: 785-794.CrossRefPubMed
5.
go back to reference Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray P. B., Jr.: Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A. 2002, 99: 2129-2133. 10.1073/pnas.042692699.PubMedCentralCrossRefPubMed Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, Casavant TL, McCray P. B., Jr.: Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A. 2002, 99: 2129-2133. 10.1073/pnas.042692699.PubMedCentralCrossRefPubMed
6.
go back to reference Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM: Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 1998, 102: 874-880.PubMedCentralCrossRefPubMed Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM: Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 1998, 102: 874-880.PubMedCentralCrossRefPubMed
7.
go back to reference Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG: hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995, 368: 331-335. 10.1016/0014-5793(95)00687-5.CrossRefPubMed Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG: hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995, 368: 331-335. 10.1016/0014-5793(95)00687-5.CrossRefPubMed
8.
go back to reference Garcia JR, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, Forssmann U, Adermann K, Kluver E, Vogelmeier C, Becker D, Hedrich R, Forssmann WG, Bals R: Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activityIts interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001, 306: 257-264. 10.1007/s004410100433.CrossRefPubMed Garcia JR, Jaumann F, Schulz S, Krause A, Rodriguez-Jimenez J, Forssmann U, Adermann K, Kluver E, Vogelmeier C, Becker D, Hedrich R, Forssmann WG, Bals R: Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activityIts interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001, 306: 257-264. 10.1007/s004410100433.CrossRefPubMed
9.
go back to reference Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG: Human beta-defensin 4: a novel inducible peptide with a specific salt- sensitive spectrum of antimicrobial activity. Faseb J. 2001, 15: 1819-1821.PubMed Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG: Human beta-defensin 4: a novel inducible peptide with a specific salt- sensitive spectrum of antimicrobial activity. Faseb J. 2001, 15: 1819-1821.PubMed
10.
go back to reference Harder J, Bartels J, Christophers E, Schroder JM: Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001, 276: 5707-5713. 10.1074/jbc.M008557200.CrossRefPubMed Harder J, Bartels J, Christophers E, Schroder JM: Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 2001, 276: 5707-5713. 10.1074/jbc.M008557200.CrossRefPubMed
11.
go back to reference Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y: Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol. 2002, 169: 2516-2523.CrossRefPubMed Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y: Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol. 2002, 169: 2516-2523.CrossRefPubMed
12.
go back to reference Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schroder JM: Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 2000, 22: 714-721.CrossRefPubMed Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schroder JM: Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 2000, 22: 714-721.CrossRefPubMed
13.
go back to reference Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA: Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun. 1998, 66: 4222-4228.PubMedCentralPubMed Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA: Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun. 1998, 66: 4222-4228.PubMedCentralPubMed
14.
go back to reference O'Neil DA, Porter E, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF: Expression and regulation of the human b-defensins hBD1 and hBD2 in intestinal epithelium. J. Immunol. 1999, 163: 6718-6724.PubMed O'Neil DA, Porter E, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF: Expression and regulation of the human b-defensins hBD1 and hBD2 in intestinal epithelium. J. Immunol. 1999, 163: 6718-6724.PubMed
15.
go back to reference Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ: Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999, 286: 525-528. 10.1126/science.286.5439.525.CrossRefPubMed Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ: Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 1999, 286: 525-528. 10.1126/science.286.5439.525.CrossRefPubMed
16.
go back to reference Dale BA, Krisanaprakornkit S: Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med. 2001, 30: 321-327. 10.1034/j.1600-0714.2001.300601.x.CrossRefPubMed Dale BA, Krisanaprakornkit S: Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med. 2001, 30: 321-327. 10.1034/j.1600-0714.2001.300601.x.CrossRefPubMed
17.
go back to reference Fellermann K, Stange EF: Defensins -- innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol. 2001, 13: 771-776. 10.1097/00042737-200107000-00003.CrossRefPubMed Fellermann K, Stange EF: Defensins -- innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol. 2001, 13: 771-776. 10.1097/00042737-200107000-00003.CrossRefPubMed
18.
go back to reference Schutte BC, McCray P. B., Jr.: [beta]-defensins in lung host defense. Annu Rev Physiol. 2002, 64: 709-748. 10.1146/annurev.physiol.64.081501.134340.CrossRefPubMed Schutte BC, McCray P. B., Jr.: [beta]-defensins in lung host defense. Annu Rev Physiol. 2002, 64: 709-748. 10.1146/annurev.physiol.64.081501.134340.CrossRefPubMed
19.
go back to reference Hennighausen LG, Sippel AE: Mouse whey acidic protein is a novel member of the family of 'four-disulfide core' proteins. Nucleic Acids Res. 1982, 10: 2677-2684.PubMedCentralCrossRefPubMed Hennighausen LG, Sippel AE: Mouse whey acidic protein is a novel member of the family of 'four-disulfide core' proteins. Nucleic Acids Res. 1982, 10: 2677-2684.PubMedCentralCrossRefPubMed
20.
go back to reference Clauss A, Lilja H, Lundwall A: A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem J. 2002, 368: 233-242. 10.1042/BJ20020869.PubMedCentralCrossRefPubMed Clauss A, Lilja H, Lundwall A: A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. Biochem J. 2002, 368: 233-242. 10.1042/BJ20020869.PubMedCentralCrossRefPubMed
21.
go back to reference Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH: Antibacterial activity of antileukoprotease. Infect Immun. 1996, 64: 4520-4524.PubMedCentralPubMed Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH: Antibacterial activity of antileukoprotease. Infect Immun. 1996, 64: 4520-4524.PubMedCentralPubMed
22.
go back to reference Sallenave JM: The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res. 2000, 1: 87-92. 10.1186/rr18.PubMedCentralCrossRefPubMed Sallenave JM: The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res. 2000, 1: 87-92. 10.1186/rr18.PubMedCentralCrossRefPubMed
23.
go back to reference Sallenave JM: Antimicrobial activity of antiproteinases. Biochem Soc Trans. 2002, 30: 111-115. 10.1042/0300-5127:0300111.CrossRefPubMed Sallenave JM: Antimicrobial activity of antiproteinases. Biochem Soc Trans. 2002, 30: 111-115. 10.1042/0300-5127:0300111.CrossRefPubMed
24.
go back to reference Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM: Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999, 452: 309-313. 10.1016/S0014-5793(99)00670-5.CrossRefPubMed Simpson AJ, Maxwell AI, Govan JR, Haslett C, Sallenave JM: Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens. FEBS Lett. 1999, 452: 309-313. 10.1016/S0014-5793(99)00670-5.CrossRefPubMed
25.
go back to reference Tomee JF, Koeter GH, Hiemstra PS, Kauffman HF: Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?. Thorax. 1998, 53: 114-116.PubMedCentralCrossRefPubMed Tomee JF, Koeter GH, Hiemstra PS, Kauffman HF: Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?. Thorax. 1998, 53: 114-116.PubMedCentralCrossRefPubMed
26.
go back to reference Wiedow O, Harder J, Bartels J, Streit V, Christophers E: Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun. 1998, 248: 904-909. 10.1006/bbrc.1998.9069.CrossRefPubMed Wiedow O, Harder J, Bartels J, Streit V, Christophers E: Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. Biochem Biophys Res Commun. 1998, 248: 904-909. 10.1006/bbrc.1998.9069.CrossRefPubMed
27.
go back to reference Thompson RC, Ohlsson K: Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. U.S.A. 1986, 83: 6692-6696.PubMedCentralCrossRefPubMed Thompson RC, Ohlsson K: Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. U.S.A. 1986, 83: 6692-6696.PubMedCentralCrossRefPubMed
28.
go back to reference Sallenave JM, Ryle AP: Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol Chem Hoppe Seyler. 1991, 372: 13-21.CrossRefPubMed Sallenave JM, Ryle AP: Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol Chem Hoppe Seyler. 1991, 372: 13-21.CrossRefPubMed
29.
go back to reference Wiedow O, Luademann J, Utecht B: Elafin is a potent inhibitor of proteinase 3. Biochem Biophys Res Commun. 1991, 174: 6-10.CrossRefPubMed Wiedow O, Luademann J, Utecht B: Elafin is a potent inhibitor of proteinase 3. Biochem Biophys Res Commun. 1991, 174: 6-10.CrossRefPubMed
30.
go back to reference Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E: Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem. 1990, 265: 14791-14795.PubMed Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E: Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem. 1990, 265: 14791-14795.PubMed
31.
go back to reference Quayle AJ: The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol. 2002, 57: 61-79. 10.1016/S0165-0378(02)00019-0.CrossRefPubMed Quayle AJ: The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol. 2002, 57: 61-79. 10.1016/S0165-0378(02)00019-0.CrossRefPubMed
32.
go back to reference Svinarich DM, Wolf NA, Gomez R, Gonik B, Romero R: Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol. 1997, 176: 470-475.CrossRefPubMed Svinarich DM, Wolf NA, Gomez R, Gonik B, Romero R: Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol. 1997, 176: 470-475.CrossRefPubMed
33.
go back to reference Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC: Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am. J. Pathol. 1998, 152: 1247-1258.PubMedCentralPubMed Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC: Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am. J. Pathol. 1998, 152: 1247-1258.PubMedCentralPubMed
34.
go back to reference Valore EV, Park CH, Quayle AJ, Wiles KR, McCray P. B., Jr., Ganz T: Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 1998, 101: 1633-1642.PubMedCentralCrossRefPubMed Valore EV, Park CH, Quayle AJ, Wiles KR, McCray P. B., Jr., Ganz T: Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J. Clin. Invest. 1998, 101: 1633-1642.PubMedCentralCrossRefPubMed
35.
go back to reference Fleming DC, King AE, Williams ARW, Critchley HOD, Kelly RW: Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril. 2003, 79: 856-863. 10.1016/S0015-0282(02)04930-0.CrossRefPubMed Fleming DC, King AE, Williams ARW, Critchley HOD, Kelly RW: Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril. 2003, 79: 856-863. 10.1016/S0015-0282(02)04930-0.CrossRefPubMed
36.
go back to reference King AE, Fleming DC, Critchley HOD, Kelly RW: Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol. 2003, In press: King AE, Fleming DC, Critchley HOD, Kelly RW: Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol. 2003, In press:
38.
go back to reference King AE, Fleming DC, Critchley HOD, Kelly RW: Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod. 2002, 8: 341-349. 10.1093/molehr/8.4.341.CrossRefPubMed King AE, Fleming DC, Critchley HOD, Kelly RW: Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod. 2002, 8: 341-349. 10.1093/molehr/8.4.341.CrossRefPubMed
39.
go back to reference King AE, Critchley HOD, Kelly RW: Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol. Hum. Reprod. 2000, 6: 191-196. 10.1093/molehr/6.2.191.CrossRefPubMed King AE, Critchley HOD, Kelly RW: Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol. Hum. Reprod. 2000, 6: 191-196. 10.1093/molehr/6.2.191.CrossRefPubMed
40.
go back to reference Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V, Ward PA: Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 1999, 154: 239-247.PubMedCentralCrossRefPubMed Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V, Ward PA: Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 1999, 154: 239-247.PubMedCentralCrossRefPubMed
41.
go back to reference Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD, Ding A: Conversion of Proepithelin to Epithelins. Roles of SLPI and Elastase in Host Defense and Wound Repair. Cell. 2002, 111: 867-878.CrossRefPubMed Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD, Ding A: Conversion of Proepithelin to Epithelins. Roles of SLPI and Elastase in Host Defense and Wound Repair. Cell. 2002, 111: 867-878.CrossRefPubMed
42.
go back to reference Zhang D, Simmen RC, Michel FJ, Zhao G, Vale-Cruz D, Simmen FA: Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J Biol Chem. 2002, 277: 29999-30009. 10.1074/jbc.M203503200.CrossRefPubMed Zhang D, Simmen RC, Michel FJ, Zhao G, Vale-Cruz D, Simmen FA: Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J Biol Chem. 2002, 277: 29999-30009. 10.1074/jbc.M203503200.CrossRefPubMed
43.
go back to reference Fahey JV, Wira CR: Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis. 2002, 185: 1606-1613. 10.1086/340512.CrossRefPubMed Fahey JV, Wira CR: Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture. J Infect Dis. 2002, 185: 1606-1613. 10.1086/340512.CrossRefPubMed
44.
go back to reference Shimoya K, Moriyama A, Ogata I, Nobunaga T, Koyama M, Azuma C, Murata Y: Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis. Mol Hum Reprod. 2000, 6: 829-834. 10.1093/molehr/6.9.829.CrossRefPubMed Shimoya K, Moriyama A, Ogata I, Nobunaga T, Koyama M, Azuma C, Murata Y: Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis. Mol Hum Reprod. 2000, 6: 829-834. 10.1093/molehr/6.9.829.CrossRefPubMed
45.
go back to reference Masson PL, Heremans JF, Ferin J: Presence of an Iron-binding protein (lactoferrin) in the genital tract of the human female. I. Its immunohistochemical localization in the endometrium. Fertil Steril. 1968, 19: 679-689.PubMed Masson PL, Heremans JF, Ferin J: Presence of an Iron-binding protein (lactoferrin) in the genital tract of the human female. I. Its immunohistochemical localization in the endometrium. Fertil Steril. 1968, 19: 679-689.PubMed
46.
go back to reference Baveye S, Elass E, Mazurier J, Spik G, Legrand D: Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med. 1999, 37: 281-286.CrossRefPubMed Baveye S, Elass E, Mazurier J, Spik G, Legrand D: Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med. 1999, 37: 281-286.CrossRefPubMed
47.
go back to reference Teng CT, Gladwell W, Beard C, Walmer D, Teng CS, Brenner R: Lactoferrin gene expression is estrogen responsive in human and rhesus monkey endometrium. Mol Hum Reprod. 2002, 8: 58-67. 10.1093/molehr/8.1.58.CrossRefPubMed Teng CT, Gladwell W, Beard C, Walmer D, Teng CS, Brenner R: Lactoferrin gene expression is estrogen responsive in human and rhesus monkey endometrium. Mol Hum Reprod. 2002, 8: 58-67. 10.1093/molehr/8.1.58.CrossRefPubMed
48.
go back to reference Singh PK, Tack BF, McCray PB Jr., Welsh MJ: Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol. 2000, 279: L799-805.PubMed Singh PK, Tack BF, McCray PB Jr., Welsh MJ: Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol. 2000, 279: L799-805.PubMed
49.
go back to reference Bulmer JN, Longfellow M, Ritson A: Leukocytes and resident blood cells in endometrium. Ann N Y Acad Sci. 1991, 622: 57-68.CrossRefPubMed Bulmer JN, Longfellow M, Ritson A: Leukocytes and resident blood cells in endometrium. Ann N Y Acad Sci. 1991, 622: 57-68.CrossRefPubMed
50.
go back to reference Loke YW, King A: Uterine Mucosal Lymphocytes. Human Implantation, Cell Biology and Immunology. Edited by: Loke YW and King A. 1995, Cambridge, Cambridge University Press, 102-129. Loke YW, King A: Uterine Mucosal Lymphocytes. Human Implantation, Cell Biology and Immunology. Edited by: Loke YW and King A. 1995, Cambridge, Cambridge University Press, 102-129.
51.
go back to reference King A: Uterine leukocytes and decidualization. Hum Reprod Update. 2000, 6: 28-36. 10.1093/humupd/6.1.28.CrossRefPubMed King A: Uterine leukocytes and decidualization. Hum Reprod Update. 2000, 6: 28-36. 10.1093/humupd/6.1.28.CrossRefPubMed
52.
go back to reference King A, Gardner L, Loke YW: Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum Reprod. 1996, 11: 1079-1082.CrossRefPubMed King A, Gardner L, Loke YW: Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum Reprod. 1996, 11: 1079-1082.CrossRefPubMed
53.
go back to reference Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO: Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab. 2003, 88: 440-449. 10.1210/jc.2002-021174.CrossRefPubMed Henderson TA, Saunders PT, Moffett-King A, Groome NP, Critchley HO: Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab. 2003, 88: 440-449. 10.1210/jc.2002-021174.CrossRefPubMed
54.
go back to reference Bulmer JN, Lunny DP, Hagin SV: Immunohistochemical characterization of stromal leucocytes in nonpregnant human endometrium. Am J Reprod Immunol Microbiol. 1988, 17: 83-90.PubMed Bulmer JN, Lunny DP, Hagin SV: Immunohistochemical characterization of stromal leucocytes in nonpregnant human endometrium. Am J Reprod Immunol Microbiol. 1988, 17: 83-90.PubMed
55.
go back to reference Kabawat SE, Mostoufi-Zadeh M, Driscoll SG, Bhan AK: Implantation site in normal pregnancy. A study with monoclonal antibodies. Am J Pathol. 1985, 118: 76-84.PubMedCentralPubMed Kabawat SE, Mostoufi-Zadeh M, Driscoll SG, Bhan AK: Implantation site in normal pregnancy. A study with monoclonal antibodies. Am J Pathol. 1985, 118: 76-84.PubMedCentralPubMed
56.
go back to reference Poropatich C, Rojas M, Silverberg SG: Polymorphonuclear leukocytes in the endometrium during the normal menstrual cycle. Int J Gynecol Pathol. 1987, 6: 230-234.CrossRefPubMed Poropatich C, Rojas M, Silverberg SG: Polymorphonuclear leukocytes in the endometrium during the normal menstrual cycle. Int J Gynecol Pathol. 1987, 6: 230-234.CrossRefPubMed
57.
go back to reference Salamonsen LA, Lathbury LJ: Endometrial leukocytes and menstruation. Hum Reprod Update. 2000, 6: 16-27. 10.1093/humupd/6.1.16.CrossRefPubMed Salamonsen LA, Lathbury LJ: Endometrial leukocytes and menstruation. Hum Reprod Update. 2000, 6: 16-27. 10.1093/humupd/6.1.16.CrossRefPubMed
58.
go back to reference Critchley HOD, Jones RL, Lea RG, Drudy TA, Kelly RW, Williams AR, Baird DT: Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab. 1999, 84: 240-248. 10.1210/jc.84.1.240.PubMed Critchley HOD, Jones RL, Lea RG, Drudy TA, Kelly RW, Williams AR, Baird DT: Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab. 1999, 84: 240-248. 10.1210/jc.84.1.240.PubMed
59.
go back to reference Critchley HOD, Kelly RW, Lea RG, Drudy TA, Jones RL, Baird DT: Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod. 1996, 11: 2257-2262.CrossRefPubMed Critchley HOD, Kelly RW, Lea RG, Drudy TA, Jones RL, Baird DT: Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod. 1996, 11: 2257-2262.CrossRefPubMed
60.
go back to reference Jones RL, Kelly RW, Critchley HOD: Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod. 1997, 12: 1300-1306. 10.1093/humrep/12.6.1300.CrossRefPubMed Jones RL, Kelly RW, Critchley HOD: Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod. 1997, 12: 1300-1306. 10.1093/humrep/12.6.1300.CrossRefPubMed
61.
go back to reference Jeziorska M, Salamonsen LA, Woolley DE: Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod. 1995, 53: 312-320.CrossRefPubMed Jeziorska M, Salamonsen LA, Woolley DE: Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod. 1995, 53: 312-320.CrossRefPubMed
62.
go back to reference Cowland JB, Johnsen AH, Borregaard N: hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 1995, 368: 173-176. 10.1016/0014-5793(95)00634-L.CrossRefPubMed Cowland JB, Johnsen AH, Borregaard N: hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 1995, 368: 173-176. 10.1016/0014-5793(95)00634-L.CrossRefPubMed
63.
go back to reference Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI: Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985, 76: 1427-1435.PubMedCentralCrossRefPubMed Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI: Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985, 76: 1427-1435.PubMedCentralCrossRefPubMed
64.
go back to reference Spitznagel JK, Dalldorf FG, Leffell MS, Folds JD, Welsh IR, Cooney MH, Martin LE: Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest. 1974, 30: 774-785.PubMed Spitznagel JK, Dalldorf FG, Leffell MS, Folds JD, Welsh IR, Cooney MH, Martin LE: Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest. 1974, 30: 774-785.PubMed
65.
go back to reference King AE, Critchley HOD, Sallenave JM, Kelly RW: Elafin in human endometrium: An anti-protease and anti-microbial molecule expressed during menstruation. J Clin Endocrinol Metab. 2003, In press: King AE, Critchley HOD, Sallenave JM, Kelly RW: Elafin in human endometrium: An anti-protease and anti-microbial molecule expressed during menstruation. J Clin Endocrinol Metab. 2003, In press:
66.
go back to reference Krensky AM: Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem Pharmacol. 2000, 59: 317-320. 10.1016/S0006-2952(99)00177-X.CrossRefPubMed Krensky AM: Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem Pharmacol. 2000, 59: 317-320. 10.1016/S0006-2952(99)00177-X.CrossRefPubMed
67.
go back to reference Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH: Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology. 2002, 106: 517-525. 10.1046/j.1365-2567.2002.01430.x.PubMedCentralCrossRefPubMed Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH: Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Immunology. 2002, 106: 517-525. 10.1046/j.1365-2567.2002.01430.x.PubMedCentralCrossRefPubMed
68.
go back to reference Di Nardo A, Vitiello A, Gallo RL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol. 2003, 170: 2274-2278.CrossRefPubMed Di Nardo A, Vitiello A, Gallo RL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol. 2003, 170: 2274-2278.CrossRefPubMed
69.
go back to reference Cates W., Jr., Wasserheit JN: Genital chlamydial infections: epidemiology and reproductive sequelae. Am. J. Obstet. Gynecol. 1991, 164: 1771-1781.CrossRefPubMed Cates W., Jr., Wasserheit JN: Genital chlamydial infections: epidemiology and reproductive sequelae. Am. J. Obstet. Gynecol. 1991, 164: 1771-1781.CrossRefPubMed
70.
go back to reference Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC: Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 1989, 161: 817-824.CrossRefPubMed Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC: Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am. J. Obstet. Gynecol. 1989, 161: 817-824.CrossRefPubMed
71.
go back to reference Cottingham J, Hunter D: Chlamydia trachomatis and oral contraceptive use: a quantitative review. Genitourin Med. 1992, 68: 209-216.PubMedCentralPubMed Cottingham J, Hunter D: Chlamydia trachomatis and oral contraceptive use: a quantitative review. Genitourin Med. 1992, 68: 209-216.PubMedCentralPubMed
72.
go back to reference Wolner-Hanssen P, Eschenbach DA, Paavonen J, Kiviat N, Stevens CE, Critchlow C, DeRouen T, Holmes KK: Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. Jama. 1990, 263: 54-59. 10.1001/jama.263.1.54.CrossRefPubMed Wolner-Hanssen P, Eschenbach DA, Paavonen J, Kiviat N, Stevens CE, Critchlow C, DeRouen T, Holmes KK: Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. Jama. 1990, 263: 54-59. 10.1001/jama.263.1.54.CrossRefPubMed
73.
go back to reference Louv WC, Austin H, Perlman J, Alexander WJ: Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol. 1989, 160: 396-402.CrossRefPubMed Louv WC, Austin H, Perlman J, Alexander WJ: Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol. 1989, 160: 396-402.CrossRefPubMed
74.
go back to reference McGregor JA, Hammill HA: Contraception and sexually transmitted diseases: interactions and opportunities. Am J Obstet Gynecol. 1993, 168: 2033-2041.CrossRefPubMed McGregor JA, Hammill HA: Contraception and sexually transmitted diseases: interactions and opportunities. Am J Obstet Gynecol. 1993, 168: 2033-2041.CrossRefPubMed
75.
go back to reference Pacora P, Maymon E, Gervasi MT, Gomez R, Edwin SS, Yoon BH, Romero R: Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes. Am. J. Obstet. Gynecol. 2000, 183: 904-910. 10.1067/mob.2000.108882.CrossRefPubMed Pacora P, Maymon E, Gervasi MT, Gomez R, Edwin SS, Yoon BH, Romero R: Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes. Am. J. Obstet. Gynecol. 2000, 183: 904-910. 10.1067/mob.2000.108882.CrossRefPubMed
76.
go back to reference Heine RP, Wiesenfeld H, Mortimer L, Greig PC: Amniotic fluid defensins: potential markers of subclinical intrauterine infection. Clin. Infect. Dis. 1998, 27: 513-518.CrossRefPubMed Heine RP, Wiesenfeld H, Mortimer L, Greig PC: Amniotic fluid defensins: potential markers of subclinical intrauterine infection. Clin. Infect. Dis. 1998, 27: 513-518.CrossRefPubMed
77.
go back to reference Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP: Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol. 2000, 183: 1243-1248. 10.1067/mob.2000.107383.CrossRefPubMed Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP: Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol. 2000, 183: 1243-1248. 10.1067/mob.2000.107383.CrossRefPubMed
78.
go back to reference McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM: Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest. 1995, 96: 456-464.PubMedCentralCrossRefPubMed McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM: Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest. 1995, 96: 456-464.PubMedCentralCrossRefPubMed
79.
go back to reference Pillay K, Coutsoudis A, Agadzi-Naqvi AK, Kuhn L, Coovadia HM, Janoff EN: Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis. 2001, 183: 653-656. 10.1086/318535.CrossRefPubMed Pillay K, Coutsoudis A, Agadzi-Naqvi AK, Kuhn L, Coovadia HM, Janoff EN: Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis. 2001, 183: 653-656. 10.1086/318535.CrossRefPubMed
80.
go back to reference Farquhar C, VanCott TC, Mbori-Ngacha DA, Horani L, Bosire RK, Kreiss JK, Richardson BA, John-Stewart GC: Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk. J Infect Dis. 2002, 186: 1173-1176. 10.1086/343805.PubMedCentralCrossRefPubMed Farquhar C, VanCott TC, Mbori-Ngacha DA, Horani L, Bosire RK, Kreiss JK, Richardson BA, John-Stewart GC: Salivary Secretory Leukocyte Protease Inhibitor Is Associated with Reduced Transmission of Human Immunodeficiency Virus Type 1 through Breast Milk. J Infect Dis. 2002, 186: 1173-1176. 10.1086/343805.PubMedCentralCrossRefPubMed
81.
go back to reference Pfundt R, van Ruissen F, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, Dijkman H, Fransen J, Croes H, van Erp PE, Schalkwijk J: Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest. 1996, 98: 1389-1399.PubMedCentralCrossRefPubMed Pfundt R, van Ruissen F, van Vlijmen-Willems IM, Alkemade HA, Zeeuwen PL, Jap PH, Dijkman H, Fransen J, Croes H, van Erp PE, Schalkwijk J: Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia. J Clin Invest. 1996, 98: 1389-1399.PubMedCentralCrossRefPubMed
82.
go back to reference Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun. 1999, 67: 2561-2566.PubMedCentralPubMed Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun. 1999, 67: 2561-2566.PubMedCentralPubMed
83.
go back to reference Casslen B, Rosengren M, Ohlsson K: Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus. Hoppe Seylers Z Physiol Chem. 1981, 362: 953-961.CrossRefPubMed Casslen B, Rosengren M, Ohlsson K: Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus. Hoppe Seylers Z Physiol Chem. 1981, 362: 953-961.CrossRefPubMed
84.
go back to reference Moriyama A, Shimoya K, Ogata I, Kimura T, Nakamura T, Wada H, Ohashi K, Azuma C, Saji F, Murata Y: Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod. 1999, 5: 656-661. 10.1093/molehr/5.7.656.CrossRefPubMed Moriyama A, Shimoya K, Ogata I, Kimura T, Nakamura T, Wada H, Ohashi K, Azuma C, Saji F, Murata Y: Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod. 1999, 5: 656-661. 10.1093/molehr/5.7.656.CrossRefPubMed
85.
go back to reference Ota Y, Shimoya K, Zhang Q, Moriyama A, Chin R, Tenma K, Kimura T, Koyama M, Azuma C, Murata Y: The expression of secretory leukocyte protease inhibitor (SLPI) in the Fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase. Hum Reprod. 2002, 17: 2517-2522. 10.1093/humrep/17.10.2517.CrossRefPubMed Ota Y, Shimoya K, Zhang Q, Moriyama A, Chin R, Tenma K, Kimura T, Koyama M, Azuma C, Murata Y: The expression of secretory leukocyte protease inhibitor (SLPI) in the Fallopian tube: SLPI protects the acrosome reaction of sperm from inhibitory effects of elastase. Hum Reprod. 2002, 17: 2517-2522. 10.1093/humrep/17.10.2517.CrossRefPubMed
86.
go back to reference Denison FC, Kelly RW, Calder AA, Riley SC: Secretory leukocyte protease inhibitor concentration increases in amniotic fluid with the onset of labour in women: characterization of sites of release within the uterus. J. Endocrinol. 1999, 161: 299-306.CrossRefPubMed Denison FC, Kelly RW, Calder AA, Riley SC: Secretory leukocyte protease inhibitor concentration increases in amniotic fluid with the onset of labour in women: characterization of sites of release within the uterus. J. Endocrinol. 1999, 161: 299-306.CrossRefPubMed
87.
go back to reference Zhang Q, Shimoya K, Moriyama A, Yamanaka K, Nakajima A, Nobunaga T, Koyama M, Azuma C, Murata Y: Production of secretory leukocyte protease inhibitor by human amniotic membranes and regulation of its concentration in amniotic fluid. Mol Hum Reprod. 2001, 7: 573-579. 10.1093/molehr/7.6.573.CrossRefPubMed Zhang Q, Shimoya K, Moriyama A, Yamanaka K, Nakajima A, Nobunaga T, Koyama M, Azuma C, Murata Y: Production of secretory leukocyte protease inhibitor by human amniotic membranes and regulation of its concentration in amniotic fluid. Mol Hum Reprod. 2001, 7: 573-579. 10.1093/molehr/7.6.573.CrossRefPubMed
88.
go back to reference Niemela A, Kulomaa M, Vija P, Tuohimaa P, Saarikoski S: Lactoferrin in human amniotic fluid. Hum Reprod. 1989, 4: 99-101.CrossRefPubMed Niemela A, Kulomaa M, Vija P, Tuohimaa P, Saarikoski S: Lactoferrin in human amniotic fluid. Hum Reprod. 1989, 4: 99-101.CrossRefPubMed
89.
go back to reference Svinarich DM, Gomez R, Romero R: Detection of human defensins in the placenta. Am J Reprod Immunol. 1997, 38: 252-255.CrossRefPubMed Svinarich DM, Gomez R, Romero R: Detection of human defensins in the placenta. Am J Reprod Immunol. 1997, 38: 252-255.CrossRefPubMed
90.
go back to reference Zhao C, Wang I, Lehrer RI: Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 1996, 396: 319-322. 10.1016/0014-5793(96)01123-4.CrossRefPubMed Zhao C, Wang I, Lehrer RI: Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 1996, 396: 319-322. 10.1016/0014-5793(96)01123-4.CrossRefPubMed
91.
go back to reference Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T, McCray P. B., Jr.: Discovery of new human beta-defensins using a genomics-based approach. Gene. 2001, 263: 211-218. 10.1016/S0378-1119(00)00569-2.CrossRefPubMed Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T, McCray P. B., Jr.: Discovery of new human beta-defensins using a genomics-based approach. Gene. 2001, 263: 211-218. 10.1016/S0378-1119(00)00569-2.CrossRefPubMed
Metadata
Title
Innate immune defences in the human endometrium
Authors
Anne E King
Hilary OD Critchley
Rodney W Kelly
Publication date
01-12-2003
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2003
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-1-116

Other articles of this Issue 1/2003

Reproductive Biology and Endocrinology 1/2003 Go to the issue